Dual Listed Biotech Firm Achieves Sale of Animal Health Interest, Sending Shares Higher
15 Aprile 2024 - 5:07PM
AllPennyStocks.com
Shares of this firm hit a 12-month high last week and are seeing
action this morning after they announced the completion of the sale
of its interest in an animal health unit for USD$8,000,000.
Kane...
To read the full story on AllPennyStocks.com, click
here.
Grafico Azioni Kane Biotech (TSXV:KNE)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Kane Biotech (TSXV:KNE)
Storico
Da Giu 2023 a Giu 2024
